BLUE

bluebird bio, Inc.

1 day chart

About BLUE

bluebird bio, Inc. is a biotechnology company. The Company is focused on researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its lentiviral vector (LVV) gene addition platform. Its lead gene therapy programs for sickle cell disease, B-thalassemia, and cerebral adrenoleukodystrophy and is advancing research to apply new technologies to these and other diseases. It has two gene therapies: ZYNTEGLO (betibeglogene autotemcel) and SKYSONA (elivaldogene autotemcel). ZYNTEGLO is the first gene therapy for people with B-thalassemia who require regular red blood cell transfusions. SKYSONA (elivaldogene autotemcel), also known as eli-cel, is used to slow the progression of eurologic dysfunction in boys 4-17 years of age with early, active cerebral adrenoleukodystrophy (CALD). It is also developing (lovotibeglogene autotemcel), also known as lovo-cel, as a one-time treatment for patients with sickle cell disease (SCD).

Buy US stocks in Australia starting with BLUE. Open an account and start investing today!

Market Capitalisation

$343.32M

Price-earnings ratio

Dividend yield

0.00%

Volume

3.12M

High today

$3.28

Low today

$3.15

Open price

$3.25

52-week high

$8.58

52-week low

$2.78

BLUE FAQs

Can I buy BLUE shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy BLUE shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of bluebird bio, Inc.?

One share of bluebird bio, Inc. is valued at $3.48.

What is the ticker symbol for bluebird bio, Inc.?

The ticker symbol for bluebird bio, Inc. is BLUE.

How do I buy BLUE shares in Australia?

To buy BLUE stocks in Australia you'll need to open an account with an investing platform like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in BLUE

What is the 52-week high for bluebird bio, Inc. stock?

The bluebird bio, Inc. 52-week high stock price is $8.58.

What is the 52-week low for bluebird bio, Inc. stock?

The bluebird bio, Inc. 52-week low stock price is $2.78.

What is the market capitalisation of bluebird bio, Inc. BLUE?

As of 21/09/2023 bluebird bio, Inc. has a market cap of $343M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.